[ASAP] LNP-miR-155 cy5 Inhibitor Regulates the Copper Transporter via the β‑Catenin/TCF4/SLC31A1 Signal for Colorectal Cancer Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00276
Source: Molecular Pharmaceutics - Category: Drugs & Pharmacology Authors: Fan Jiang, Le Du, Zhi-ju Chen, Xiang Wang, Dongsheng Ge, and Ning Liu Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Colorectal Cancer | Copper | Drugs & Pharmacology